Dr. King is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Seattle Cancer Care Alliance
Seattle, WA 98109Phone+1 206-606-7222
Education & Training
- University of ColoradoFellowship, Hematology and Medical Oncology, 2018
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2014
- University of Santo TomasClass of 2007
Certifications & Licensure
- WA State Medical License 2019 - 2025
- CO State Medical License 2018 - 2021
- PA State Medical License 2010 - 2016
Clinical Trials
- Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer Start of enrollment: 2020 Jul 08
Publications & Presentations
PubMed
- 2 citationsTreatment Patterns in US Patients Receiving First-Line and Second-Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma in the Real World.Gentry King, Stacie Ittershagen, Luyang He, Ying Shen, Frank Li
Advances in Therapy. 2022-12-01 - 16 citationsKRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.Adam C Diehl, Lindsay M Hannan, David B Zhen, Andrew L Coveler, Gentry King
The Oncologist. 2022-12-09 - 14 citationsOutcome of neoadjuvant treatment for pancreatic cancer in elderly patients: comparative, observational cohort studyAtsushi Oba, Y H A Wu, Christopher H. Lieu, Cheryl Meguid, Kathryn L. Colborn
The British Journal of Surgery. 2021-08-19
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: